Abstract
Testing of living surgical bone and deceased tissue donors by NHS Blood and Transplant (NHSBT) has included individual donation (ID) nucleic acid testing (NAT) for HBV, HCV and HIV since 2008. Here, the well-established window period methodology was used to estimate residual risk (RR). Prevalence of viral markers was calculated among both tissue donor populations. Incidence was derived by adjusting incidence among new blood donors by the prevalence ratio for tissue and new blood donors. Residual risk (RR) was calculated as the product of incidence and duration of WP for single donor HBV NAT at 0.058 years (21 days), HCV NAT at 0.008 years (3 days) and HIV NAT at 0.014 (5 days). Between 2013 and 2017, 7886 living surgical bone donors were tested, 16 were positive for markers of HBV, HCV and HIV. HCV had the highest prevalence at 114/100,000 donors. Incidence and RR was highest for HBV at 3.55/100,000-person years and 0.32/100,000 donors (95% CI 0.11/100,000–1.42/100,000). Among 9751 deceased tissue donors tested, 22 were positive for viral markers. HBV had highest prevalence at 174/100,000 donors, and the highest incidence and RR at 8.12/100,000 person years and 0.74/100,000 donors (95% CI 0.08/100,000–2.99/100,000). Using ID NAT, RR of not detecting a HBV, HCV and HIV WP donation among tissue donors is less than 1/100,000 donors. These estimates provide a good starting point for discussing potential risks of viral transmission through tissue transplant with patients.
Similar content being viewed by others
Availability of data and material
The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
References
Brant LJ, Davison KL (2008) Infections detected in English surgical bone and deceased donors (2001–2006) and estimated risk of undetected hepatitis B and hepatitis C virus. Vox Sang 95:272–279
Brant LJ, Davison KL (2009) Addendum to Vox Sanguinis 2008, 95:272–279. Vox Sang 97:277
CDC (2003) Hepatitis C Virus transmission from an antibody-negative organ and tissue donor—United States, 2000–2002. MMWR Weekly 52(13):273–276
Davison KL, Ushiro-Lumb I, Lawrance M, Trotter P, Powell JJ, Brailsford SR (2019) Infections and associated behaviors among deceased organ donors: informing the assessment of risk. Transpl Infect Dis 21:e13055
Eastlund T (1995) Infectious disease transmission through cell, tissue, and organ transplantation: reducing the risk through donor selection. Cell Transplant 4:455–477
Hinsenkamp M, Muylle L, Eastlund T, Fehily D, Noel L, Strong DM (2012) Adverse reactions and events related to musculoskeletal allografts: reviewed by the World Health Organisation Project NOTIFY. Int Orthop 36:633–641
Hoft RH, Pflugfelder SC, Forster RK, Ullman S, Polack FM, Schiff ER (1997) Clinical evidence for hepatitis B transmission resulting from corneal transplantation. Cornea 16:132–137
Locasciulli A, Alberti A, Bandini G, Polchi P, Arcese W, Alessandrino P, Bosi A, Testa M, Bacigalupo A (1995) Allogeneic bone marrow transplantation from HBsAg+ donors: a multicenter study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Blood 86:3236–3240
Reynolds C, Davison KL, Brailsford SR (2019) Safe supplies: few infections in UK blood and tissue donors. Transfus Med 29:239–246
Soldan K, Barbara JA, Ramsay ME, Hall AJ (2003) Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993–2001. Vox Sang 84:274–286
Soldan K, Davison K, Dow BC (2005) Estimates of the frequency of HBV, HCV, and HIV infectious donations entering the blood supply in the United Kingdom, 1996 to 2003. Eurosurveillance 10:9–10
Acknowledgments
Thanks go to tissue donors and their families, and to colleagues at NHSBT for reporting to the surveillance scheme
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest.
Consent for publication
Appropriate approval has been given by Public Health England.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Davison, K.L., Chandrasekar, A. & Brailsford, S.R. Re-assessing the risk of undetected HBV, HCV and HIV in deceased tissue and living surgical bone donors in England. Cell Tissue Bank 22, 635–641 (2021). https://doi.org/10.1007/s10561-021-09927-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10561-021-09927-7